{"id":"https://openalex.org/W76815796","doi":null,"title":"Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate.","display_name":"Imatinib mesylate and dermatology part 2: a review of the cutaneous side effects of imatinib mesylate.","alternate_titles":[],"publication_year":2006,"publication_date":"2006-03-01","ids":{"openalex":"https://openalex.org/W76815796","mag":"76815796","pmid":"https://pubmed.ncbi.nlm.nih.gov/16573254"},"language":"en","primary_location":{"id":"pmid:16573254","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16573254","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W76815796"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026266004","display_name":"Noah S. Scheinfeld","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1321572752","display_name":"St. Luke's-Roosevelt Hospital Center","ror":"https://ror.org/011t2cn48","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1321572752"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Noah Scheinfeld","raw_affiliation_strings":["Department of Dermatology, St. Luke's-Roosevelt Hospital Center, New York, NY 10025, USA. Scheinfeld@earthlink.net"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, St. Luke's-Roosevelt Hospital Center, New York, NY 10025, USA. Scheinfeld@earthlink.net","institution_ids":["https://openalex.org/I1321572752"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5026266004"],"corresponding_institution_ids":["https://openalex.org/I1321572752"],"apc_list":null,"apc_paid":null,"fwci":9.2674,"has_fulltext":false,"cited_by_count":130,"citation_normalized_percentile":{"value":0.98386864,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"5","issue":"3","first_page":"228","last_page":"231"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","score":0.9696999788284302,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.0284000001847744,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/imatinib-mesylate","display_name":"imatinib mesylate","score":0.996999979019165},{"id":"https://openalex.org/keywords/drug-induced-skin-reaction","display_name":"drug-induced skin reaction","score":0.9589999914169312},{"id":"https://openalex.org/keywords/toxic-epidermal-necrolysis","display_name":"toxic epidermal necrolysis","score":0.9350000023841858},{"id":"https://openalex.org/keywords/stevens-johnson-syndrome","display_name":"Stevens-Johnson syndrome","score":0.9929999709129333},{"id":"https://openalex.org/keywords/acute-generalized-exanthematous-pustulosis","display_name":"acute generalized exanthematous pustulosis","score":0.9369999766349792},{"id":"https://openalex.org/keywords/purpura-fulminans","display_name":"purpura fulminans","score":0.7379999756813049},{"id":"https://openalex.org/keywords/porphyria-cutanea-tarda","display_name":"porphyria cutanea tarda","score":0.8820000290870667},{"id":"https://openalex.org/keywords/sweet-syndrome","display_name":"Sweet syndrome","score":0.9440000057220459},{"id":"https://openalex.org/keywords/erythema-nodosum","display_name":"erythema nodosum","score":0.878000020980835},{"id":"https://openalex.org/keywords/squamous-cell-carcinoma","display_name":"squamous cell carcinoma","score":0.7770000100135803},{"id":"https://openalex.org/keywords/syringoma","display_name":"syringoma","score":0.6650000214576721},{"id":"https://openalex.org/keywords/follicular-mucinosis","display_name":"follicular mucinosis","score":0.9509999752044678},{"id":"https://openalex.org/keywords/pseudolymphoma","display_name":"pseudolymphoma","score":0.7900000214576721},{"id":"https://openalex.org/keywords/corticosteroid-therapy","display_name":"corticosteroid therapy","score":0.8769999742507935}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9455053806304932},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.7921155095100403},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.5942171812057495},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.5335723757743835},{"id":"https://openalex.org/C2780461338","wikidata":"https://www.wikidata.org/wiki/Q1125160","display_name":"Pityriasis rosea","level":2,"score":0.528751790523529},{"id":"https://openalex.org/C2777073666","wikidata":"https://www.wikidata.org/wiki/Q1592207","display_name":"Pseudolymphoma","level":3,"score":0.4885593354701996},{"id":"https://openalex.org/C2779515644","wikidata":"https://www.wikidata.org/wiki/Q718675","display_name":"Drug eruption","level":3,"score":0.44176191091537476},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.3218587040901184},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14977073669433594},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.1385881006717682},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.08084744215011597},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.07601618766784668},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":true},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":2,"locations":[{"id":"pmid:16573254","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16573254","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of drugs in dermatology : JDD","raw_type":"Journal Article"},{"id":"mag:76815796","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16573254","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3029469582","https://openalex.org/W2160871451","https://openalex.org/W1990502771","https://openalex.org/W2141463412","https://openalex.org/W2981852555","https://openalex.org/W2750239821","https://openalex.org/W2084384393","https://openalex.org/W2075546308","https://openalex.org/W1597914077","https://openalex.org/W2092076142"],"abstract_inverted_index":{"Cutaneous":[0],"reactions":[1,72],"to":[2,10,55],"imatinib":[3,76,130,136],"are":[4,27,138],"common":[5,30],"and":[6,24,41,48,69,122,137],"occur":[7],"in":[8],"9.5%":[9],"69%":[11],"of":[12,58,93,111,135,146,154],"patients":[13],"depending":[14],"on":[15],"the":[16,28,56],"series":[17],"reported.":[18],"Maculopapular":[19],"eruptions,":[20,22,86,121],"erythematous":[21],"edema,":[23],"periorbital":[25],"edema":[26],"most":[29],"adverse":[31],"events":[32],"observed.":[33],"Imatinib":[34,60],"can":[35,151],"also":[36],"induce":[37],"severe":[38],"skin":[39,43],"eruptions":[40,127],"generalized":[42,64],"eruptions.":[44],"Toxic":[45],"epidermal":[46],"necrolysis":[47],"Stevens":[49],"Johnson":[50],"syndrome":[51],"has":[52,61,73],"been":[53],"linked":[54],"use":[57],"imatinib.":[59],"caused":[62,128],"acute":[63],"exanthematous":[65],"pustulosis.":[66],"Purpuric":[67],"vasculitis":[68],"mycosis":[70],"fungoides-like":[71],"occurred":[74],"after":[75],"use.":[77],"Rarer":[78],"side":[79,157],"effects":[80],"include:":[81],"hypopigmentation,":[82],"lichenoid":[83],"reactions,":[84],"pityriasiform":[85],"pityriasis":[87],"rosea,":[88],"psoriasis,":[89],"reactivation":[90],"or":[91,148],"induction":[92,110],"porphyria":[94],"cutanea":[95],"tarda,":[96],"neutrophilic":[97],"eccrine":[98],"hidradenitis,":[99],"Sweet's":[100],"syndrome,":[101],"erythema":[102],"nodosum,":[103],"EBV-positive":[104],"cutaneous":[105,126,156],"B-cell":[106],"lymphoproliferative":[107],"disease,":[108],"possible":[109],"squamous":[112],"cell,":[113],"hyaline":[114],"cell":[115],"syringomas,":[116],"follicular":[117],"mucinosis,":[118],"pseudolymphoma-type":[119],"drug":[120],"malpighian":[123],"epitheliomas.":[124],"Most":[125],"by":[129],"do":[131],"not":[132],"necessitate":[133],"discontinuance":[134],"usually":[139],"self":[140],"limited,":[141],"despite":[142],"continued":[143],"treatment.":[144],"Administration":[145],"oral":[147],"topical":[149],"corticosteroids":[150],"ameliorate":[152],"some":[153],"imatinib's":[155],"effects.":[158]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W76815796","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":12}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
